Skip to content
Alpha Edge Investing

Alpha Edge Investing

"Investors operate with limited funds and limited intelligence, they don’t need to know everything. As long as they understand better than others, they have an edge.” – George Soros

  • Home
  • Earnings Updates/ Corporate Actions
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trust/ ETF
  • News
  • My Opinions/ Views
  • Others
  • About Me
  • Contact
  • Disclaimer
  • Community and Support Forums
  • Toggle search form

UOBKH: Genting SP – Steep Gaming Volume Recovery; Trending Closer To Pre-pandemic Levels (Overweight)

Posted on July 22, 2022July 22, 2022 By alanyeo No Comments on UOBKH: Genting SP – Steep Gaming Volume Recovery; Trending Closer To Pre-pandemic Levels (Overweight)

FLASH NOTE

Gaming

MBS 2Q22: Steep Gaming Volume Recovery; Trending Closer To Pre-pandemic LevelsMBS delivered an impressive quarter with 2Q22 net gaming revenue recovering 90% qoq to exceed pre-pandemic levels. This was supported by excellent local patronage and a robust mass market segment (mass volume recovered to 79% of pre-pandemic levels), as well as the strong recovery of international visitors and the VIP market segment (VIP volume recovered to 76% of pre-pandemic levels). Overall, we remain confident Singapore’s casinos are well-positioned to ride on the strength of the nation’s tourism recovery and expect 80-90% GGR growth in 2022. Maintain our OVERWEIGHT call for the sector and BUY call for Genting Singapore.

·        MBS: Resilient gaming volume recovery. Las Vegas Sands’ (LVS) 2Q22 results reveal that Marina Bay Sands’ (MBS) adjusted EBITDA surged 185% yoy to US$319m (hold-normalised adjusted EBITDA improved 187% yoy to US$278m), the highest quarterly figure since the onset of the COVID-19 pandemic. MBS’ 2Q22 net gaming revenue also recovered 90.1% qoq to hit 108% of pre-pandemic levels. On a constant currency basis (in Singapore dollars), 2Q22’s mass market (table and slot) gross gaming revenue (GGR) rose 71% yoy and 44% qoq, while VIP GGR surged 507% yoy and 276% qoq. Mass:VIP GGR mix for tables (ie excluding slots) stood at 48:52 in 2Q22 (1Q22: 69:31, 2Q21: 72:28). MBS’ 2Q22 EBITDA margin also improved to 47.0% (1Q22: 30.3%, 2Q21: 34.3%).

·        Mass market: Stellar mass volume coupled with higher win rates. In Singapore dollars, we estimate that MBS’ mass market non-rolling chip volume rose 113% yoy to represent the highest quarter since 2Q20 (96% of pre-pandemic levels), while slot handle improved 34% yoy to a historical high and exceeds pre-pandemic levels. With higher overall mass volumes at +143% yoy and higher win rates, mass table GGR surged 117% yoy while slot GGR surged 37% yoy in 2Q22. The overall mass market GGR improved 71% yoy.  

·        VIP: RCV increased meaningfully yoy, lifted by lower win rates. On a constant currency basis, we estimate MBS’ 2Q22 rolling chip volume (RCV) rose 811.2% yoy (+189% qoq) and represented 76% of pre-pandemic levels, mainly due to Singapore’s lifting of border restrictions. Furthermore, the stronger RCV was supplemented by a higher win rate of 4.29% in 2Q22 (1Q22: 3.3%), resulting in a 279% qoq increase in GGR. Meanwhile, RCV improved 811% yoy. Despite the win rate plunging to 4.29% (2Q21: 6.44%), VIP GGR spiked 507% yoy in 2Q22 on much stronger RCV.

·        RWS: Expecting a similarly solid quarter with significant gaming volume recovery. We expect Resorts World Singapore to deliver a similarly commendable GGR as MBS in 2Q22, which represents >100% of pre-pandemic levels. With the world eventually fully unwinding COVID-19 curbs, we expect Genting Singapore’s EBITDA to claw back to the pre-pandemic level of S$1.2b in FY23 as the worst is likely over. Meanwhile, we also expect international visitors to trickle in with Singapore relaxing social distancing measures and border restrictions.

·        Maintain OVERWEIGHT as we anticipate strong GGR recovery after Singapore’s border opening. Singapore has scrapped the previous quota-based Vaccinated Travel Lane arrangement and replaced it with a new Vaccinated Travel Framework which allows fully-vaccinated travellers to enter Singapore free of quarantine and on-arrival tests. Since 26 April, pre-departure tests are no longer required for inoculated travellers to enter Singapore. Subsequently, we expect the gaming industry to benefit from surging international patronage and GGR.

·        Maintain BUY on Genting Singapore with a target price of S$1.08, which implies 8.8x 2023F EV/EBITDA (-0.5SD below mean). We continue to expect the cash-flushed company (net cash accounts for 33% of market cap) to engage in significantly better capital management moving forward.

Gaming-_MBS_2Q22-_Steep_Gaming_Volume_Recovery_Trending_Closer_To_Pre-pandemic_LevelsClick here to Download Full Report in PDF

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
Research - Equities Tags:Genting SP

Post navigation

Previous Post: UOBKH: Singapore Technology Manufacturers (Overweight)
Next Post: CIMB: Mapletree Logistics Trust – Add Target Price $2.05 (Previous $2.10)

Related Posts

UOBKH: Gaming Singapore (Overweight) Research - Equities
UOBKH: Singapore Monthly Review and Outlook Research - Equities
UOBKH: STRATEGY – SINGAPORE Research - Equities
KGI: Genting Singapore (GENS SP) – “Rooms” are hot Research - Equities
DBS: Singapore Equity Picks – Guarding our performance 19 Sep 2022 Research - Equities
UOBKH: Singapore Strategy Research - Equities
OIR: Genting SP – Buy Target Price $0.92 Research - Equities
DBS: Genting Singapore – Buy Target Price $1.00 Research - Equities
UOBKH: Genting Singapore – Buy Target Price $1.08 Research - Equities
CIMB: Genting Singapore – Add Target Price $1.04 Research - Equities
UOBKH: Monthly Review and Outlook – Singapore Research - Equities
UOBKH: Singapore Strategy – Alpha Picks Research - Equities

Leave a Reply

You must be logged in to post a comment.

Login

Log In
Register Lost Password
Get new posts by email
Chat on WhatsApp
  • Earnings Updates/ Corporate Actions
  • My Opinions/ Views
  • News
  • Others
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trusts/ ETF

Copyright © 2023 Alpha Edge Investing.

Powered by PressBook Grid Blogs theme